Kymera Therapeutics Inc (KYMR)
Healthcare
Biotechnology
100.30 $
-3.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Kymera Therapeutics Inc (KYMR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -89 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -35 | -32 | 8.0 | -40 | -43 | -50 | -62 | -79 | -60 | -27 | -67 | -89 | -243 | |
| 0.9 | 0.9 | 0.9 | 1.5 | 1.9 | 2.0 | 2.0 | 2.0 | 2.1 | 2.1 | 2.0 | 2.0 | 8.3 | |
| 11 | 12 | 11 | 12 | 14 | 15 | 14 | 14 | 15 | 16 | 14 | 16 | 62 | |
| 9.8 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 8.0 | 9.8 | -0.5 | 1.9 | 11 | 1.4 | 3.4 | -27 | 1.4 | 38 | 5.8 | -35 | 11 | |
| 11 | 8.1 | 12 | 7.4 | 4.7 | 0.2 | 0.9 | 0.5 | 0.7 | 0.2 | 0.1 | 0.4 | 1.4 | |
| 36 | 61 | 19 | -331 | 16 | -158 | 69 | 49 | 60 | -235 | -394 | -143 | -713 | |
| -0.3 | – | – | – | – | -0.6 | -0.3 | -0.3 | -0.4 | -0.4 | -0.4 | -0.4 | -1.6 | |
| 1.3 | -0.2 | 1.9 | 354 | 1.4 | 251 | 2.8 | 0.3 | 246 | 40 | 705 | 19 | 1,009 | |
| 1.9 | 29 | 29 | -16 | -26 | 43 | 9.5 | -30 | 246 | -223 | 244 | -213 | 54 | |
| -46 | -40 | -3.6 | -47 | -48 | -50 | -63 | -80 | -61 | -27 | -67 | -89 | -244 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.